Search - tctmd.com

Displaying 201 - 220 of 408

Sort: Relevancy | Date

News Daily News

Cardiac Abnormalities Seen After COVID-19, but Recovery Is Quick

Michael O'Riordan

January 20, 2022

News Daily News

Myocardial Injury Tied to Greater Mortality 1 Year After COVID-19 Hospitalization

Todd Neale

January 06, 2022

News Opinion CV Team Dispatch

January 2022 News Roundup

L.A. McKeown

January 01, 2022

News Daily News

Women Less Likely Than Men to Experience SCD During Sports

Michael O'Riordan

December 21, 2021

News Daily News

FDA Approves Two Additional Indications for Rivaroxaban in Children

L.A. McKeown

December 21, 2021

News Features

Cath Lab Teams Find Enduring Lessons in COVID-19’s Unending Reign

L.A. McKeown

December 20, 2021

News Daily News

For Angina Patients, Language Barriers Can Complicate CVD Care

Caitlin E. Cox

December 20, 2021

News Daily News

Meta-analysis of Pivotal SGLT2 Inhibitor Trials Boosts Hopes in HFpEF

L.A. McKeown

December 07, 2021

News Opinion CV Team Dispatch

December 2021 News Roundup

L.A. McKeown

December 01, 2021

News Conference News AHA 2021

Dietary Patterns, Social Pressures: AHA Offers New Nutrition Advice

Caitlin E. Cox

November 19, 2021

News Conference News AHA 2021

Small CRAVE Trial Reassures on Caffeine Safety in Rhythm Disorders

L.A. McKeown

November 14, 2021

News Opinion Editor's Corner AHA 2021

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

Shelley Wood

November 08, 2021

News Opinion CV Team Dispatch

November 2021 News Roundup

L.A. McKeown

November 01, 2021

News Daily News

Rivaroxaban Again Linked to More Bleeding vs Other DOACs

Caitlin E. Cox

October 11, 2021

News Daily News

Social Determinants of Health Drive Racial CVD Risk Differences

Yael L. Maxwell

October 06, 2021

News Daily News

Infective Endocarditis Rare After AVR, but Often a Killer When It Occurs

Michael O'Riordan

October 01, 2021

News Daily News

High Burden of CAD in Chest Pain Patients With ‘Normal’ Troponin

Michael O'Riordan

September 27, 2021

News Conference News HFSA 2021

PRESERVED-HF: Dapagliflozin Improves Symptoms, Physical Limitations in HFpEF

Todd Neale

September 13, 2021

News Daily News

CMS Pays More to Male Cardiologists, but the Reasons Why Are Murky

Michael O'Riordan

September 10, 2021

News Opinion CV Team Dispatch

September 2021 News Roundup

L.A. McKeown

September 01, 2021

Advertisement

Cardiac Abnormalities Seen After COVID-19, but Recovery Is Quick

Myocardial Injury Tied to Greater Mortality 1 Year After COVID-19 Hospitalization

January 2022 News Roundup

Women Less Likely Than Men to Experience SCD During Sports

FDA Approves Two Additional Indications for Rivaroxaban in Children

Cath Lab Teams Find Enduring Lessons in COVID-19’s Unending Reign

For Angina Patients, Language Barriers Can Complicate CVD Care

Meta-analysis of Pivotal SGLT2 Inhibitor Trials Boosts Hopes in HFpEF

December 2021 News Roundup

Dietary Patterns, Social Pressures: AHA Offers New Nutrition Advice

Small CRAVE Trial Reassures on Caffeine Safety in Rhythm Disorders

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

November 2021 News Roundup

Rivaroxaban Again Linked to More Bleeding vs Other DOACs

Social Determinants of Health Drive Racial CVD Risk Differences

Infective Endocarditis Rare After AVR, but Often a Killer When It Occurs

High Burden of CAD in Chest Pain Patients With ‘Normal’ Troponin

PRESERVED-HF: Dapagliflozin Improves Symptoms, Physical Limitations in HFpEF

CMS Pays More to Male Cardiologists, but the Reasons Why Are Murky

September 2021 News Roundup

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content